Achalasia of Cardia: Symptoms and Treatments

Achalasia is a rare esophageal disorder that affects the ability of the esophagus to move food toward the stomach. The term "achalasia" is derived from the Greek word for "failure to relax," which aptly describes the primary issue faced by patients: the inability of the lower esophageal sphincter (LES) to relax and allow food to pass into the stomach. As a result, individuals with achalasia often experience difficulty swallowing, regurgitation of undigested food, and chest pain.

---

Symptoms of Achalasia

The symptoms of achalasia can be debilitating and significantly impact a person's quality of life. Early recognition of these symptoms is crucial for prompt diagnosis and treatment.

Common Symptoms

The primary symptoms of achalasia include:

Achalasia Type 3 Symptoms

Achalasia can be classified into three types based on manometric findings, with Type 3 being the most severe. Type 3 achalasia, also known as spastic achalasia, is characterized by:

---

Pathophysiology of Achalasia Cardia

Understanding the pathophysiology of achalasia cardia is essential for grasping how this disorder affects the esophagus.

Esophageal Dysfunction

Achalasia is primarily characterized by two key dysfunctions:

Neurological Factors

The exact cause of achalasia remains unclear, but it is believed to involve the degeneration of nerve cells in the esophageal wall, particularly the myenteric plexus. This degeneration disrupts the normal signaling required for LES relaxation and peristalsis. While the precise trigger for this neuronal damage is unknown, autoimmune factors and viral infections have been proposed as potential contributors.

Genetic and Environmental Factors

Genetic predisposition and environmental factors may also play a role in the development of achalasia. Some studies suggest a higher prevalence of achalasia among certain ethnic groups and families, indicating a possible genetic link. Environmental triggers, such as infections or toxins, may also contribute to the onset of the disease.

---

Causes of Achalasia Cardia

The exact etiology of achalasia cardia remains elusive, but several potential causes have been identified.

Autoimmune Hypothesis

One prevailing theory is that achalasia may have an autoimmune component. In this scenario, the body's immune system mistakenly targets and damages the nerve cells in the esophagus, leading to the characteristic dysfunctions of the LES and esophageal peristalsis.

Viral Infections

Viral infections have also been implicated in the development of achalasia. Some studies have detected viral particles in the esophageal tissues of achalasia patients, suggesting that a viral infection may trigger the immune response that damages the nerve cells.

Genetic Factors

As mentioned earlier, there is evidence to suggest a genetic predisposition to achalasia. Familial cases of achalasia have been reported, supporting the idea that genetic factors may contribute to the susceptibility to this disorder.

Environmental Triggers

Environmental factors, such as exposure to certain toxins or infections, may act as triggers for the onset of achalasia in genetically predisposed individuals. However, more research is needed to identify specific environmental factors involved.

---

Treatment Options for Achalasia

Treating achalasia aims to relieve symptoms, improve esophageal function, and enhance the patient's quality of life. Treatment options can be broadly categorized into non-surgical and surgical approaches.

Non-Surgical Treatments

Pharmacological Therapy

Medications such as nitrates and calcium channel blockers can help relax the LES and alleviate symptoms. However, their effectiveness is limited, and they are generally considered a temporary solution.

Botulinum Toxin Injection

Botulinum toxin (Botox) injections into the LES can temporarily paralyze the muscles, allowing for improved relaxation and symptom relief. This treatment is minimally invasive but typically provides only short-term benefits, necessitating repeated injections.

Pneumatic Dilation

Pneumatic dilation involves the insertion of a balloon into the LES, which is then inflated to stretch and disrupt the muscle fibers. This procedure can provide long-lasting relief for many patients but carries a risk of esophageal perforation.

Surgical Treatments

Heller Myotomy

Heller myotomy is a surgical procedure that involves cutting the muscle fibers of the LES to reduce the functional obstruction. This can be performed using either an open or laparoscopic approach. The procedure is often combined with a partial fundoplication to prevent postoperative reflux.

Peroral Endoscopic Myotomy (POEM)

POEM is a less invasive alternative to Heller myotomy, performed endoscopically. During POEM, an endoscope is inserted through the mouth, and a myotomy is performed from within the esophageal wall. This technique has shown promising results in terms of symptom relief and recovery time.